A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

NCT06084962 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Relapse/Refractory Multiple Myeloma

Interventions

BIOLOGICAL: DeepTag-GPRC5D Targeted CAR T-cells

Sponsor

He Huang

Collaborators

[object Object]